Bhekisisa: Help us choose a winner
One of our reader letters will win a one-year digital subscription to the Mail & Guardian. Help us decide who deserves it.
Why has Gauteng run out of ARVs?
Patients go without key drugs as the province and suppliers trade blame for antiretroviral shortages.
State consolidates HIV treatment
New medicine combines ARVs into one pill, making them easier to supply.
Impoverished patients benefit from rejected drug patent
After a seven-year battle, India's government has successfully defended its right to reject drug patents if a medicine doesn't deserve one.
Health matters: Let’s Bhekisisa it
The M&G's new health journalism centre is ready to make its mark, scrutinise and inform.
Funding crisis looms large
HIV counsellors play a vital role in Lesotho's health system, but the money is running out.
Opinion: TB cannot be kept behind bars
World TB Day is on March 24: We look at plans to curb the disease's spread – in prisons and beyond.
[From our archives]’Smart drugs’ rife at universities
Students are abusing schedule six pills ahead of exams – with the help of their doctors.
Opinion: SA should use Brics membership to strengthen research
South Africa has a lot to learn about efficient and effective ways to approach health research and policy, suggests John Ouma-Mugabe.
Health sector cleared for surgery
An industry-wide probe into private healthcare seems likely, but stakeholders fear a witch hunt.